Independent Director · Trevi Therapeutics, Inc. (TRVI)

Chair, Compensation Committee

Michael Heffernan director compensation at Trevi Therapeutics: $283K

Fiscal year 2025 director compensation for Michael Heffernan at Trevi Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 21, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Michael Heffernan’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Michael Heffernan and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Trevi Therapeutics Director Compensation Table · all 4 fiscal years held
In US dollars, as Trevi Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$65,000$0$218,430$0$283,430
FY2024$65,000—$68,246—$133,246
FY2023$65,000—$62,947—$127,947
FY2021$57,500—$32,770—$90,270

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Trevi Therapeutics, Inc. DEF 14A filed April 21, 2026, accession 0001193125-26-166695, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Trevi Therapeutics, Inc. filed document, accession 0001193125-26-166695. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2026.

Get the Trevi Therapeutics Board Governance Report

$283,430 Michael Heffernan, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 21, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Trevi Therapeutics pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit · Compensation (Chair)

The rest of the Trevi Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Anne VanLentIndependent Director$283,430
David Meeker, M.DIndependent Director$293,430
Dominick ColangeloIndependent Director$275,930
Edward MathersIndependent Director$265,930
Jennifer GoodDirector—

The full Trevi Therapeutics compensation record

free company brief

This page is one director within Trevi Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Trevi Therapeutics proxy · each links to its own free brief

Order TRVI

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report